Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family (Hsp40) member C24 (abbreviated DNAJC24) is an evolutionarily conserved heat shock protein that acts as a co-chaperone, stimulating ATPase activity in Hsp70-type chaperones, and is critical for diphthamide biosynthesis, a post-translational modification in translation elongation factor 2 (EEF2)[1][8]. This modification is the target for inactivation by diphtheria toxin and Pseudomonas exotoxin A. DNAJC24 possesses iron-binding and electron-carrying properties and regulates cellular stress responses including protein folding, autophagy, and cell motility[1][2][8]. DNAJC24 expression is elevated in several cancers (notably hepatocellular carcinoma and lung adenocarcinoma), correlates with poor prognosis, and may serve as a biomarker and potential therapeutic target to inhibit cancer cell proliferation by disrupting cellular stress adaptation and ammonia metabolism[2][5].
Targeting DNAJC24 (e.g., by RNA interference) can suppress cell proliferation, motility, and autophagy in HCC cells, interfering with ammonia metabolism and possibly other stress-related pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member C24 (DNAJC24).